Academy of Pediatrics (AAP) guidelines promote HCW personal protective equipment (PPE) use to prevent respiratory virus transmission in pediatric clinics; however, adherence to recommendations is inconsistent. We evaluated the effectiveness of two strategies designed to cue HCW use of PPE in a pediatric primary care clinic.
Background. Endotracheal aspirate cultures (EACs) are commonly obtained in many PICUs. However, EACs cannot distinguish between bacterial colonization and infection, and may promote antibiotic overuse if collected in patients without clinical signs and symptoms of ventilator-associated infections (VAIs). We examined clinician's reasons to obtain EACs and whether the results informed clinical management.
Methods. We conducted a structured survey of nurse practitioners and physicians caring for ventilated children to inform a quality improvement initiative to optimize the use of EACs in the PICU at a tertiary care children's hospital. We assessed EACs obtained from patients mechanically ventilated for at least 24 hours from November 2017 to February 2018. This was a 2-part survey: part 1 conducted within 1-2 days after obtaining an EAC, part 2 conducted after EACs results were reported.
Results. 25 surveys were completed. Nearly half (44%) of EACs were obtained for isolated clinical signs of fever, hypotension, laboratory abnormalities, or ventilator increases, while the remainder were obtained for a combination of reasons. Most EACs (60%) were collected as a "pan culture" with urine and blood cultures, and 92% of EACs had a previous EAC. At the time of ordering, providers thought the EAC would help with diagnosis of VAI (68%), antibiotic selection (80%), and believed it was very important for the patient's management (60%). After results were available, 40% of patients were given a diagnosis of VAI. Antibiotic therapy was discontinued in 12% and modified in 16% based on the EAC results. Antibiotics were changed based on a different test in 52%, or unchanged in 20%. Of the patients with a prior EAC, 72% of EACs resulted the same or fewer bacteria. On follow-up, 56% of the providers reported the EAC provided little to no value for the patient's management.
Conclusion. A large proportion of EACs were obtained due to isolated changes in a patient's clinical status and most EACs were obtained from patients who had prior EACs. Results were often similar to prior EAC results, infrequently led to changes in antibiotic selection and many providers did not find the results helpful. These findings suggest there is opportunity to standardize and reduce the use of EACs in the PICU.
Disclosures. All authors: No reported disclosures. Background. Cat scratch disease (CSD) is caused by B henselae, a Gram-negative intracellular bacilli which is transmitted to humans via cat bite/scratch. Typical CSD presents as regional lymphadenopathy and fever. However, there are multiple atypical presentations of cat scratch disease that have been reported including prolonged fever, absence of lymphadenopathy and systemic complications such hepatosplenic disease, osteomyelitis, Parinaud oculoglandular syndrome, neuroretinitis, encephalitis, and bacillary angiomatosis among other rare presentations. The aim of this study was to review the frequency, presentation, and treatment outcomes of aytpical CSD presentations at Nationwide Children's Hospital (Columbus OH).
Atypical Cat Scratch Disease Presentations
Methods. This was a retrospective study performed at Nationwide Children's Hospital, Columbus, OH. EMR of patients were reviewed between January 2010 and March 2017 using ICD9 or ICD 10 codes for CSD. Patients were identified on the basis of compatible clinical presentation and confirmatory serological test or PCR results for B. henselae. Clinical, radiological, and histopathological findings were collected Results. A total of 204 patients were serologically diagnosed as having cat scratch disease between January 2010 and July 2017. Of the 204 cases, 166 (81%) had typical CSD and 38 (18.6%) had atypical CSD. Of the atypical manifestations, 20 (52%) patients had no lymphadenopathy, 12 (31%) had osteomyelitis, 12 (31%) patients had hepatic and/or splenic microabscesses, 4 (10.5%) had osteomyelitis and hepatic/ splenic involvement, 3 (1.5%) had encephalitis, 2 (5.2%) had neuroretinitis, and there was one case each (2.6%) of Parinaud oculoglandular syndrome, uveitis, pulmonary cavitary lesion, myocarditis, and endocarditis. Fever of unknown origin was present in 28 (75.6%) of the atypical CSD cases. The median duration of antibiotic treatment was 25 days (IQR 31) and median duration of illness in patients with atypical CSD was 51 days (IQR 56). The majority of patients were treated with dual antibiotic therapy that included rifampin.
Conclusion. In children with fever of unknown origin, serologic testing for CSD should be performed even in the absence of lymphadenopathy and a search for underlying systemic complications is recommended for prompt diagnosis and appropriate treatment.
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